Currently holds a position at Pliant Therapeutics Inc
Position | Company | Period |
---|---|---|
President, Chief Executive Officer, Director | Pliant Therapeutics Inc | Jan. 1, 2017 - |
Chief Executive Officer | Pliant Therapeutics Inc | None - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-07-19 | 2023-07-17 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
70,150
-17.0%
18.011,263,338 USD |
70,150 -17.0% | 18.01 | 1,263,338 USD | |
2023-04-03 | 2023-03-30 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
35,339
-11.4%
26.52937,222 USD |
35,339 -11.4% | 26.52 | 937,222 USD | |
2023-02-06 | 2023-02-03 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
5,262
-2.1%
34.08179,312 USD |
5,262 -2.1% | 34.08 | 179,312 USD | |
2023-02-06 | 2023-02-03 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
9,738
-3.8%
33.36324,888 USD |
9,738 -3.8% | 33.36 | 324,888 USD | |
2023-02-06 | 2023-02-02 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
1,605
-0.7%
34.9656,105 USD |
1,605 -0.7% | 34.96 | 56,105 USD | |
2023-02-06 | 2023-02-02 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
13,395
-5.3%
34.13457,124 USD |
13,395 -5.3% | 34.13 | 457,124 USD | |
2023-02-01 | 2023-02-01 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
105
-0.0%
35.553,733 USD |
105 -0.0% | 35.55 | 3,733 USD | |
2023-02-01 | 2023-02-01 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
5,440
-2.2%
34.78189,192 USD |
5,440 -2.2% | 34.78 | 189,192 USD | |
2023-02-01 | 2023-02-01 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
9,455
-3.7%
34.15322,841 USD |
9,455 -3.7% | 34.15 | 322,841 USD | |
2023-02-01 | 2023-01-31 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
15,000
-5.9%
34.92523,755 USD |
15,000 -5.9% | 34.92 | 523,755 USD | |
2023-02-01 | 2023-01-30 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
3,605
-1.5%
34.66124,938 USD |
3,605 -1.5% | 34.66 | 124,938 USD | |
2023-02-01 | 2023-01-30 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
11,395
-4.5%
33.98387,177 USD |
11,395 -4.5% | 33.98 | 387,177 USD | |
2023-01-27 | 2023-01-27 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
221
-0.1%
36.648,097 USD |
221 -0.1% | 36.64 | 8,097 USD | |
2023-01-27 | 2023-01-27 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
9,779
-2.3%
35.09343,158 USD |
9,779 -2.3% | 35.09 | 343,158 USD | |
2023-01-27 | 2023-01-27 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
6,302
-2.6%
36.06227,243 USD |
6,302 -2.6% | 36.06 | 227,243 USD | |
2023-01-27 | 2023-01-27 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
8,698
-3.4%
35.42308,046 USD |
8,698 -3.4% | 35.42 | 308,046 USD | |
2023-01-27 | 2023-01-26 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
15,000
-3.5%
35.10526,425 USD |
15,000 -3.5% | 35.10 | 526,425 USD | |
2023-01-27 | 2023-01-26 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
15,000
-5.9%
35.29529,367 USD |
15,000 -5.9% | 35.29 | 529,367 USD | |
2023-01-25 | 2023-01-25 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
1,696
-1.8%
33.2956,459 USD |
1,696 -1.8% | 33.29 | 56,459 USD | |
2023-01-25 | 2023-01-25 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
13,304
-12.2%
32.40431,058 USD |
13,304 -12.2% | 32.40 | 431,058 USD | |
2023-01-25 | 2023-01-24 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
15,000
-13.8%
30.89463,389 USD |
15,000 -13.8% | 30.89 | 463,389 USD | |
2023-01-25 | 2023-01-23 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
15,000
-3.3%
35.00525,000 USD |
15,000 -3.3% | 35.00 | 525,000 USD | |
2023-01-25 | 2023-01-23 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
4,850
-4.9%
34.93169,405 USD |
4,850 -4.9% | 34.93 | 169,405 USD | |
2023-01-25 | 2023-01-23 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
10,150
-9.3%
33.71342,163 USD |
10,150 -9.3% | 33.71 | 342,163 USD | |
2023-01-09 | 2023-01-09 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
5,000
-5.1%
19.1795,829 USD |
5,000 -5.1% | 19.17 | 95,829 USD | |
2023-01-09 | 2023-01-06 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
15,000
-13.8%
19.04285,584 USD |
15,000 -13.8% | 19.04 | 285,584 USD | |
2023-01-05 | 2023-01-04 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
15,000
-13.8%
19.06285,941 USD |
15,000 -13.8% | 19.06 | 285,941 USD | |
2023-01-05 | 2023-01-03 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
15,000
-13.8%
19.33289,952 USD |
15,000 -13.8% | 19.33 | 289,952 USD | |
2022-12-21 | 2022-12-20 |
Pliant Therapeutics Inc
(PLRX)
|
S Sale |
34,212
-26.7%
19.10653,531 USD |
34,212 -26.7% | 19.10 | 653,531 USD | |
2022-09-14 | 2022-09-12 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
12,502
-17.4%
22.54281,851 USD |
12,502 -17.4% | 22.54 | 281,851 USD | |
2022-07-13 | 2022-07-12 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
12,498
-17.4%
22.50281,205 USD |
12,498 -17.4% | 22.50 | 281,205 USD | |
2022-07-13 | 2022-07-11 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
15,000
-20.2%
22.50337,500 USD |
15,000 -20.2% | 22.50 | 337,500 USD | |
2021-05-17 | 2021-05-14 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
503
-0.1%
29.2814,726 USD |
503 -0.1% | 29.28 | 14,726 USD | |
2021-05-17 | 2021-05-14 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
2,997
-0.7%
28.5385,499 USD |
2,997 -0.7% | 28.53 | 85,499 USD | |
2021-04-15 | 2021-04-14 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
3,500
-0.8%
30.33106,161 USD |
3,500 -0.8% | 30.33 | 106,161 USD | |
2021-03-17 | 2021-03-15 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
178
-0.0%
39.697,064 USD |
178 -0.0% | 39.69 | 7,064 USD | |
2021-03-17 | 2021-03-15 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
2,000
-0.4%
38.7577,501 USD |
2,000 -0.4% | 38.75 | 77,501 USD | |
2021-03-17 | 2021-03-15 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
1,322
-0.3%
38.0350,270 USD |
1,322 -0.3% | 38.03 | 50,270 USD | |
2021-02-17 | 2021-02-16 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
200
-0.0%
34.076,814 USD |
200 -0.0% | 34.07 | 6,814 USD | |
2021-02-17 | 2021-02-16 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
2,100
-0.5%
32.8769,018 USD |
2,100 -0.5% | 32.87 | 69,018 USD | |
2021-02-17 | 2021-02-16 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
1,200
-0.3%
32.1038,520 USD |
1,200 -0.3% | 32.10 | 38,520 USD | |
2021-01-15 | 2021-01-14 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
630
-0.1%
27.2117,145 USD |
630 -0.1% | 27.21 | 17,145 USD | |
2021-01-15 | 2021-01-14 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
2,870
-0.6%
26.2075,180 USD |
2,870 -0.6% | 26.20 | 75,180 USD | |
2020-12-16 | 2020-12-14 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
337
-0.1%
27.869,388 USD |
337 -0.1% | 27.86 | 9,388 USD | |
2020-12-16 | 2020-12-14 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
3,163
-0.7%
27.3286,402 USD |
3,163 -0.7% | 27.32 | 86,402 USD |